| CardioChek PA Metabolic Syndrome Panel, 15 ct. |
|
| Metabolic Chemistry Panel, Measures HDL, Triglycerides & Glucose, (for use with CardioChek PA only), 15 ct, more ... |
|
Health Products >
Medical Instuments >
Test Strips
|
|
Note: This product can only be shipped in the USA.
|
|
|
|
|
Features
An entire Metabolic Chemistry pro.le in just two minutes. That’s a turn-around time that can dramatically improve patient care and caseload e.ciency. The Metabolic Chemistry Panel for use with the CardioChek PA point-of-care instrument o.ers a fast, easy and convenient method for large-scale testing. With this panel, you can measure three of the .ve risk factors associated with metabolic syndrome – HDL cholesterol, triglycerides, and glucose. So in two minutes, following NCEP revised ATP III guidelines, you’re able to use the information to assist in diagnosis and treatment (or referral) decisions. For use with the CardioChek PA Professional Blood Testing Device Only
Advantages of the Metabolic Chemistry Panel
- Enhanced patient compliance to medications and lifestyle changes
- Single fingerstick – only 1 drop of blood for all three tests
- Results in only 2 minutes – helps increase patient flow and efficiency
- Immediate feedback – counsel patients at the point-of-care
- Battery-operated, portable device – easy to use and transport
- Convenient package size – 15 test strips per vial
- No refrigeration required – long shelf-life at room temperature
- FDA-cleared, CLIA-waived, CE marked
What is metabolic syndrome?
Metabolic syndrome is a constellation of risk factors that increase the chances for developing cardiovascular disease.
According to the American Heart Association, up to 25% of US adults have metabolic syndrome 2. The ATP III guidelines
recognize metabolic syndrome as a secondary target of risk reduction, after an elevated LDL cholesterol level. Goals for
managing metabolic syndrome include reducing underlying causes (i.e., obesity and physical inactivity) and treating
associated non-lipid and lipid risk factors.
Diagnosing metabolic syndrome
The National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III guidelines identify .ve risk factors; any three may constitute a
diagnosis of metabolic syndrome:1 The chart below displays decision points to determine risk. For all risk factors except HDL, the optimal condition
is lower than the decision point. For HDL, the optimal condition is higher than the decision point.
| Elevated waist circumferance |
Elevated triglycerides |
Reduced HDL cholesterol |
Elevated blood pressure |
Fasting plasma glucose |
>102 cm ( >40” in men) |
.150 mg/dL ( .1.7 mmol/L) |
<40 mg/dL ( <1.04 mmol/L in men) |
.130 mmHg systolic blood pressure |
.110 mg/dL (.6.1 mmol/L) |
>88 cm ( >35” in women) |
or drug treatment for elevated triglycerides |
<50 mg/dL (<1.30 mmol/L in women) |
.85 mmHg diastolic blood pressure |
or drug treatment for elevated glucose |
|
|
or drug treatment for reduced HDL cholesterol |
|
|
Range: Glucose: 20-600 mg/dL (1.11 -33.3 mmol/L)
HDL Cholesterol: 25-100 mg/dL (0.65-2.59 mmol/L)
Triglycerides: 50-500 mg/dL (0.56-5.65 mmol/L)
Time: about 2 minutes
Sample: 40 µL whole blood (fingerstick or venous)
Analyzer: CardioChek PA only
CLIA: Waived
Weight:
1.00 lb
|
|
|
|
|
|
| |
|
|